Skip to main content
Kane Biotech
Biofilms
Overview
Understanding Biofilms
coactiv+™
DispersinB
®
Glossary Of Terms
Commercialization Vehicles
Overview
Kane Wound Care & Surgical
Kane Dermatology
About
Overview
Our Team
Careers
Contact
Publications
Blog
Publications / Posters
News / Events
Investors
Overview
News / Events
Company Information
Financial Results
Stock Data
SEDAR
Corporate Governance
Press Releases
Kane Biotech is a biotechnology company engaged in the research, development and commercialization of technologies and products that prevent and remove microbial biofilms.
Investors
Overview
News / Events
Press Releases
IR Calendar
Email Alerts
Company Info
Profile
Overview of Kane Wound Care
DermaKB OTC Shampoo Trials
Presentations
Management Team
Contacts
Financial Results
Stock Data
TSX-V:KNE
OTCQB:KNBIF
SEDAR
Governance
Board of Directors
Board Committees
Governance Documents
Investor Tools
Email Alerts
Tear Sheet
Contacts
RSS News Feed
News / Events
Press Releases
IR Calendar
Email Alerts
All News
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
Kane Biotech – Q2 2017 Financial Results
Aug 16, 2017
Kane Biotech Announces Removal of All Debt from its Balance Sheet and Grant of Options
Jul 24, 2017
Kane Biotech Announces Closing of Over-Sold Private Placement Offering
Jul 17, 2017
Kane Biotech Announces Closing of Loan Transaction
Jun 27, 2017
Kane Biotech Announces Private Placement Offering
Jun 1, 2017
Kane Biotech - Q1 2017 Financial Reports
May 17, 2017
Kane Biotech - Business and Intellectual Property Update
May 11, 2017
Kane Biotech Announces Issuance of Common Shares in Payment of Outstanding Interest
Mar 27, 2017
Kane Biotech Announces Completion of Share Consolidation
Mar 10, 2017
Kane Biotech Announces Exclusive License and Distribution Agreement with Dechra
Mar 6, 2017
1...
18
19
20
21
22
23
24
25
26
27
...39
